Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities

被引：0
作者：
Voris, JC [1 ]
机构：
[1] Univ S Carolina, Coll Pharm, Dorn Vet Hosp, Columbia, SC 29208 USA
来源：
JOURNAL OF CLINICAL PSYCHOLOGY | 1999年 / 55卷 / 01期
关键词：
D O I：
10.1002/(SICI)1097-4679(199901)55:1<129::AID-JCLP13>3.0.CO;2-0
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
The average daily dose and need for dose escalations for the drugs known as selective serotonin reuptake inhibitors (SSRIs) has frequently been a point of controversy. This study reports on the information gathered from nine Veterans Affairs hospitals over a two six-month periods. Average daily doses of fluoxetine. paroxetine. and sertraline started at 30.9 mg. 24.2 mg. and 87.8 mg and ended at 28.4 mg. 24.2 mg. and 89.8 mg. respectively. Cost, number of prescriptions, and dosage strength data is also presented. (C) 1999 John Wiley & Sons, Inc.
引用
收藏
页码：129 / 133
页数：5
相关论文
共 15 条
  • [1] Review of clinical use of sertraline by family practice physicians in a small Air Force hospital
    Bourgeois, MJA
    [J]. MILITARY MEDICINE, 1996, 161 (07) : 425 - 427
  • [2] CLAGHORN JL, 1993, J CLIN PSYCHOPHARM, V13, pS23
  • [3] DOOGAN DP, 1988, J CLIN PSYCHIAT, V49, P46
  • [4] DUNNER DL, 1992, J CLIN PSYCHIAT, V53, P21
  • [5] SERTRALINE SAFETY AND EFFICACY IN MAJOR DEPRESSION - A DOUBLE-BLIND FIXED-DOSE COMPARISON WITH PLACEBO
    FABRE, LF
    ABUZZAHAB, FS
    AMIN, M
    CLAGHORN, JL
    MENDELS, J
    PETRIE, WM
    DUBE, S
    SMALL, JG
    [J]. BIOLOGICAL PSYCHIATRY, 1995, 38 (09) : 592 - 602
  • [6] HIGH-DOSE FLUOXETINE IN THE TREATMENT OF DEPRESSED-PATIENTS NOT RESPONSIVE TO A STANDARD DOSE OF FLUOXETINE
    FAVA, M
    ROSENBAUM, JF
    COHEN, L
    REITER, S
    MCCARTHY, M
    STEINGARD, R
    CLANCY, K
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1992, 25 (04) : 229 - 234
  • [7] FAVA M, 1995, J CLIN PSYCHIAT, V56, P52
  • [8] GREGOR KJ, 1994, CLIN THER, V16, P306
  • [9] A 1-YEAR DOUBLE-BLIND PLACEBO-CONTROLLED FIXED-DOSE STUDY OF SERTRALINE IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
    GREIST, JH
    JEFFERSON, JW
    KOBAK, KA
    CHOUINARD, G
    DUBOFF, E
    HALARIS, A
    KIM, SW
    KORAN, L
    LIEBOWTIZ, MR
    LYDIARD, B
    MCELROY, S
    MENDELS, J
    RASMUSSEN, S
    WHITE, K
    FLICKER, C
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (02) : 57 - 65
  • [10] PAROXETINE - AN OVERVIEW OF DOSAGE, TOLERABILITY, AND SAFETY
    JENNER, PN
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 6 : 69 - 80
12